Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7

Aim: Neo-adjuvant chemotherapy is a common approach for the complex treatment of breast cancer (BC) and paclitaxel (PTX) is frequently included in the therapeutic regimen. However, the effect of PTX-based treatment is hard to predict precisely based on routinely used markers. As microRNAs are consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Apollonova, Vera, Plevako, Daniil, Garanin, Alexandr, Sidina, Elena, Zabegina, Lidia, Knyazeva, Margarita, Smirnova, Viktoria, Artemyeva, Anna, Krivorotko, Petr, Malek, Anastasia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571055/
https://www.ncbi.nlm.nih.gov/pubmed/37842231
http://dx.doi.org/10.20517/cdr.2023.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571055/
https://www.ncbi.nlm.nih.gov/pubmed/37842231
http://dx.doi.org/10.20517/cdr.2023.19

Ejemplares similares